Gastroparesis Trial, Recruiting NCT06046833 Sponsor: Samita Garg Condition: Gastroparesis
Back to Gastroparesis

Gastroparesis Trial, Recruiting

NCT06046833
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older.
  • You have been diagnosed with type 1 or type 2 diabetes for at least one year.
  • Your HbA1c blood sugar level (a measure of average blood sugar over 3 months) was 11% or below within the last 6 months.
  • Your thyroid hormone levels were normal within the past year.
  • You have not had a serious diabetes-related emergency (such as dangerously high or low blood sugar) requiring an ER visit or hospital stay in the past 2 weeks.
  • If you have gastroparesis (a condition where the stomach empties too slowly), you have had symptoms for at least the past 3 months.
  • If you have gastroparesis, you have had a specific stomach-emptying test confirming delayed emptying within the past 5 years (confirm with trial site).
  • You own a smartphone (iPhone or Android) that can run the LibreView app.

Who may not be able to join:

  • Your HbA1c blood sugar level is above 11% at the time of joining.
  • You have advanced kidney disease or significantly reduced kidney function (confirm with trial site).
  • You have serious heart disease or unstable chest pain.
  • You have advanced liver disease that affects your blood sugar levels.
  • You have had an organ transplant.
  • You have had surgery on your stomach in the past.
  • You currently have active symptoms of celiac disease, such as diarrhea, nausea, vomiting, or stomach pain.
  • You are pregnant, or you are a woman of childbearing age who is not using adequate birth control for at least 28 days.
  • You are currently taking steroids, immune-suppressing medications, or undergoing chemotherapy or radiation that could affect blood sugar levels.
  • You are currently taking opioid pain medications or certain diabetes/weight-loss injections (such as Ozempic, Wegovy, Mounjaro, or Trulicity) — though you may be eligible after stopping these for 2 weeks.
  • You use recreational or illegal drugs such as marijuana, cocaine, or opiates.
  • You are currently taking certain stomach-motility medications such as Reglan, Motegrity, Cisapride, Domperidone, or Erythromycin — though you may be eligible after stopping these for 1 week.
  • You have significant abnormal findings from a recent upper digestive tract camera examination (endoscopy).
  • Imaging has shown a blockage in your stomach or intestines.
  • You have previously participated in this study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Samita Garg, MD, The Cleveland Clinic

Phone: 216-444-2384

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Samita Garg
Registry
ClinicalTrials.gov
Start date
8 January 2024
Est. completion
1 March 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Time-in-Range (TIR); Time-in-Tight Range (TITR); Time Below Range (TBR); Time Above Range (TAR); Metrics of Glucose Variability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov